SUPPRESSORS OF CYTOKINE SIGNALING AND IL-10 INHIBITORY EFFECT IN LYME DISEASE
莱姆病中细胞因子信号传导的抑制剂和 IL-10 抑制作用
基本信息
- 批准号:7562286
- 负责人:
- 金额:$ 3.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAnti-inflammatoryBorrelia burgdorferiCellsComputer Retrieval of Information on Scientific Projects DatabaseCytokine Inducible SH2-Containing ProteinDataDiseaseFundingGene ExpressionGenesGrantInflammationInflammatoryInflammatory ResponseInstitutionInterleukin-10Interleukin-6LifeLyme DiseaseMediatingMusOrder SpirochaetalesOspA proteinPathogenesisPlayProductionRNA InterferenceResearchResearch PersonnelResourcesReverse Transcriptase Polymerase Chain ReactionRoleSmall Interfering RNASourceTimeUnited States National Institutes of Healthcytokinedisorder controlmacrophage
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Lyme disease, caused by the spirochete Borrelia burgdorferi, is an inflammatory disease. Inflammation, as induced by the spirochete, plays a major role in disease pathogenesis. The anti-inflammatory cytokine IL-10 has been shown to be a key regulator of inflammatory responses in Lyme disease, by controlling the production and function of various pro-inflammatory cytokines. Recently we observed that B. burgdorferi together with IL-10 additively induced the expression of the suppressor of cytokine signaling (SOCS)1 and 3 in macrophages. SOCS1/SOCS3 expression correlated with the IL-10-mediated inhibition of several pro-inflammatory cytokines. We hypothesized that the expression of SOCS induced by B. burgdorferi and IL-10 in macrophages is functionally important in the IL-10-mediated control of inflammation in macrophages. We used RNAi to silence the SOCS3 gene in mouse J774 macrophages stimulated with either live B. burgdorferi (Bb) or lipidated outer surface protein A (L-OspA) alone, or each stimulant together with IL-10. Using a SOCS3 specific pool of 4 siRNA molecules we achieved up to 79% knockdown of SOCS3 gene expression in cells transfected with the SOCS3 siRNA as compared to cells transfected with a nontargeting control siRNA, as assessed by real-time RT-PCR. IL-6 production was increased in culture supernatants with stimulants combined with IL-10 and SOCS3 siRNA as compared to those containing control siRNA. Taken together, these data suggest that SOCS3 may be involved in the IL-10 control of inflammation in macrophages.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
莱姆病是由伯氏疏螺旋体引起的一种炎症性疾病。由螺旋体引起的炎症在疾病的发病机制中起着重要作用。抗炎细胞因子IL-10通过控制各种促炎细胞因子的产生和功能,被证明是莱姆病炎症反应的关键调节因子。最近,我们观察到伯氏杆菌和IL-10共同诱导巨噬细胞表达细胞因子信号转导抑制因子(SOCS)1和3。SOCS1/SOCS3的表达与IL-10介导的对几种促炎细胞因子的抑制有关。我们推测,伯氏杆菌和IL-10诱导的巨噬细胞SOCs的表达在IL-10介导的巨噬细胞炎症控制中具有重要的功能。我们使用RNAi沉默了活的伯氏杆菌(BB)或脂化的外表面蛋白A(L-OspA)单独刺激的小鼠J774巨噬细胞中的SOCS3基因,或者两种刺激剂与IL-10一起刺激。使用SOCS3特异性的4个siRNA分子池,我们实现了SOCS3 siRNA细胞中SOCS3基因表达的抑制,与非靶向对照siRNA细胞相比,实时荧光RT-PCR检测到了高达79%的下调。刺激剂联合IL-10和SOCS3 siRNA后,培养上清液中IL-6的产量较对照siRNA明显增加。综上所述,这些数据表明SOCS3可能参与了IL-10对巨噬细胞炎症的控制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIDA A DENNIS其他文献
VIDA A DENNIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIDA A DENNIS', 18)}}的其他基金
Mechanisms and protective efficacy of nanovaccines against Chlamydia trachomatis
纳米疫苗对沙眼衣原体的作用机制及防护效果
- 批准号:
8684660 - 财政年份:2014
- 资助金额:
$ 3.04万 - 项目类别:
Mechanisms and protective efficacy of nanovaccines against Chlamydia trachomatis
纳米疫苗对沙眼衣原体的作用机制及防护效果
- 批准号:
8899432 - 财政年份:2014
- 资助金额:
$ 3.04万 - 项目类别:
RISE Option II:NIGMS-Research Initiative for Scientific Enhancement (RISE) Program at ASU
RISE 选项 II:NIGMS-亚利桑那州立大学科学增强研究计划 (RISE) 计划
- 批准号:
10624258 - 财政年份:2013
- 资助金额:
$ 3.04万 - 项目类别:
RISE Option II:NIGMS-Research Initiative for Scientific Enhancement (RISE) Program at ASU
RISE 选项 II:NIGMS-亚利桑那州立大学科学增强研究计划 (RISE) 计划
- 批准号:
10412025 - 财政年份:2013
- 资助金额:
$ 3.04万 - 项目类别:
RISE Option II:NIGMS-Research Initiative for Scientific Enhancement (RISE) Program at ASU
RISE 选项 II:NIGMS-亚利桑那州立大学科学增强研究计划 (RISE) 计划
- 批准号:
10176526 - 财政年份:2013
- 资助金额:
$ 3.04万 - 项目类别:
REGULATION OF SOCS EXPRESSION IN MACROPHAGES IN RESPONSE TO BORRELIA AND IL-10
巨噬细胞中 SOCS 表达对疏螺旋体和 IL-10 的调节
- 批准号:
7958643 - 财政年份:2009
- 资助金额:
$ 3.04万 - 项目类别:
TOLL-LIKE RECEPTOR MEDIATES INFLAMMATORY RESPONSES TO BORRELIA BURGDORFERI
Toll 样受体介导伯氏疏螺旋体的炎症反应
- 批准号:
7958719 - 财政年份:2009
- 资助金额:
$ 3.04万 - 项目类别:
SUPPRESSORS OF CYTOKINE SIGNALING AND IL-10 INHIBITORY EFFECT IN LYME DISEASE
莱姆病中细胞因子信号传导的抑制剂和 IL-10 抑制作用
- 批准号:
7958604 - 财政年份:2009
- 资助金额:
$ 3.04万 - 项目类别:
SUPPRESSORS OF CYTOKINE SIGNALING AND IL-10 INHIBITORY EFFECT IN LYME DISEASE
莱姆病中细胞因子信号传导的抑制剂和 IL-10 抑制作用
- 批准号:
7716220 - 财政年份:2008
- 资助金额:
$ 3.04万 - 项目类别:
CHLAMYDIA TRACHOMATIS VACCINE STUDIES IN NONHUMAN PRIMATES
非人灵长类动物沙眼衣原体疫苗研究
- 批准号:
7716310 - 财政年份:2008
- 资助金额:
$ 3.04万 - 项目类别:
相似海外基金
Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
- 批准号:
23K07659 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
- 批准号:
23K15705 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
- 批准号:
23K19490 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
- 批准号:
10697567 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
- 批准号:
10727765 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
- 批准号:
23K13905 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
- 批准号:
23K08467 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
- 批准号:
493138 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
- 批准号:
2223225 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
- 批准号:
10651054 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别: